Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine

Author:

Santillo M1,Sivyer K1ORCID,Krusche A1,Mowbray F1,Jones N2,Peto T E A234,Walker A S34,Llewelyn M J5ORCID,Yardley L16,Lee Amy,Sargent Catherine,Butler Chris,Roseveare Chris,Agranoff Daniel,Lockwood Debbie,Lyon Donald,Cross Elizabeth,Darwin Elizabeth,Barlow Gavin,Setchfield Ian,Islam Jasmin,Wright Juliet,Hand Kieran,Vaughan Louella,Wilcox Mark,Wiselka Martin,Sharland Mike,Jones Nicola,Fawcett Nicola,Wade Paul,Martin Dachsel R,Sierra Rachaeol,Bellamy Richard,Pires Sacha,Curtis Sally,Lippett Samantha,Crossland Sue,Hopkins Susan,Garcia-Arias Veronica,Gudka Vikesh,Hamilton Will,Gorton Clifford,

Affiliation:

1. Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK

2. Oxford University Hospitals NHS Foundation Trust, Oxford, UK

3. Nuffield Department of Medicine, University of Oxford, Oxford, UK

4. NIHR Biomedical Centre, Oxford, UK

5. Brighton and Sussex Medical School, University of Sussex, Falmer, UK

6. School of Psychological Science, University of Bristol, Bristol, UK

Abstract

Abstract Background Hospital antimicrobial stewardship strategies, such as ‘Start Smart, Then Focus’ in the UK, balance the need for prompt, effective antibiotic treatment with the need to limit antibiotic overuse using ‘review and revise’. However, only a minority of review decisions are to stop antibiotics. Research suggests that this is due to both behavioural and organizational factors. Objectives To develop and optimize the Antibiotic Review Kit (ARK) intervention. ARK is a complex digital, organizational and behavioural intervention that supports implementation of ‘review and revise’ to help healthcare professionals safely stop unnecessary antibiotics. Methods A theory-, evidence- and person-based approach was used to develop and optimize ARK and its implementation. This was done through iterative stakeholder consultation and in-depth qualitative research with doctors, nurses and pharmacists in UK hospitals. Barriers to and facilitators of the intervention and its implementation, and ways to address them, were identified and then used to inform the intervention’s development. Results A key barrier to stopping antibiotics was reportedly a lack of information about the original prescriber’s rationale for and their degree of certainty about the need for antibiotics. An integral component of ARK was the development and optimization of a Decision Aid and its implementation to increase transparency around initial prescribing decisions. Conclusions The key output of this research is a digital and behavioural intervention targeting important barriers to stopping antibiotics at review (see http://bsac-vle.com/ark-the-antibiotic-review-kit/ and http://antibioticreviewkit.org.uk/). ARK will be evaluated in a feasibility study and, if successful, a stepped-wedge cluster-randomized controlled trial at acute hospitals across the NHS.

Funder

National Institute for Health Research

NIHR

NIHR Biomedical Research Centre

BRC

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3